Search Menu
Photonics Media Photonics Buyers' Guide Photonics Spectra BioPhotonics EuroPhotonics Vision Spectra Photonics Showcase Photonics ProdSpec Photonics Handbook

Opsens Profits Down Amid Development Push

Facebook Twitter LinkedIn Email Comments
QUEBEC CITY, July 3, 2014 — Fiber sensing firm Opsens Inc. reported a net loss of CA$1.2 million in its third quarter, citing fees related to a licensing agreement and development costs related to an arterial pressure sensor due to hit the market next year.

The company said it is seeking regulatory approval in the U.S., Canada, Europe and Japan for its fractional flow reserve (FFR) products. During the third quarter a cardiologist at the Quebec Heart and Lung Institute performed FFR measurements on 18 patients during coronary angiograms. Results of the study have not been released.

Meanwhile, the company entered into a US$6 million co-development agreement with Abiomed Inc. under which Opsens will supply the sub-assembly of its miniature optical pressure sensor to be integrated in Abiomed’s circulatory assist devices.

Opsens reported revenues of CA$1.7 million in the third quarter, essentially equal to the same period last year. It said lower revenues in it oil and gas segment were offset by higher revenues in its industrial segment. The company reported a net loss of (Canadian) $689,000 in its third quarter last year.

For more information, visit
Jul 2014
AmericasAsia-PacificBiophotonicsBusinessCanadaEuropefiber opticsFractional Flow ReserveindustrialJapanOpsensQuebecSensors & DetectorsAbiomed Inc.miniature optical pressure sensor

back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2020 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, [email protected]

Photonics Media, Laurin Publishing
x We deliver – right to your inbox. Subscribe FREE to our newsletters.
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.